“EFFECT OF PERIPHERAL NEUROMODULATION ON HEADACHE IN POST COVID-19 SURVIVORS” (2022) Journal of Pharmaceutical Negative Results, pp. 2694–2704. doi:10.47750/pnr.2022.13.S07.361.